Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Honz Pharmaceutical
Guangzhou, Guangdong, Chinahonz.com.cn ↗
- Ownership
- Private
- Employees
- ~751
- Development stage
- Other
01
Overview
Honz Pharmaceutical focuses on pediatric and family medicines, with a strong presence in China’s children’s healthcare market. Its portfolio includes both Chinese and Western medicines, with several approved products such as Zhike Juhong Granules for cough and combination therapies like ibuprofen/phenylephrine hydrochloride in late-stage clinical development or approved status. The company has a leading domestic position in child drug R&D and production capacity.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Small moleculeHerbal medicine
- Industry
- Biotech
02
Partnerships
No major global pharmaceutical partnerships publicly disclosed.
Beyond the preview
Go deeper on Honz Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Honz Pharmaceutical.